Mauro Zaccarelli
Mauro Zaccarelli
Dirigente Medico, INMI "Lazzaro Spallanzani, Roma
Verified email at inmi.it
Title
Cited by
Cited by
Year
Combination antiretroviral therapy and the risk of myocardial infarction
Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
New England Journal of Medicine 349 (21), 1993-2003, 2003
19612003
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
A Mocroft, B Ledergerber, C Katlama, O Kirk, P Reiss, AA Monforte, ...
The Lancet 362 (9377), 22-29, 2003
15042003
Liver-related deaths in persons infected with the human immunodeficiency virus: the D: A: D study
S Collins, T Mertenskoetter, E Loeliger, R Tressler, I Weller, N Friis-M°ller, ...
Archives of internal medicine 166 (15), 1632-1641, 2006
13322006
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D: A: D study: a multi-cohort collaboration
D: A: D Study Group
The Lancet 371 (9622), 1417-1426, 2008
10172008
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration
CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ...
The Lancet 384 (9939), 241-248, 2014
7032014
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients
AA Monforte, AC Lepri, G Rezza, P Pezzotti, A Antinori, AN Phillips, ...
Aids 14 (5), 499-507, 2000
6762000
Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort
D Konopnicki, A Mocroft, S De Wit, F Antunes, B Ledergerber, C Katlama, ...
Aids 19 (6), 593-601, 2005
6472005
AIDS across Europe, 1994–98: the EuroSIDA study
A Mocroft, C Katlama, AM Johnson, C Pradier, F Antunes, F Mulcahy, ...
The Lancet 356 (9226), 291-296, 2000
5882000
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients
A Mocroft, O Kirk, P Reiss, S De Wit, D Sedlacek, M Beniowski, J Gatell, ...
Aids 24 (11), 1667-1678, 2010
4382010
Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study
A Mocroft, R Brettle, O Kirk, A Blaxhult, JM Parkin, F Antunes, P Francioli, ...
Aids 16 (12), 1663-1671, 2002
3812002
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study
N Friis-M°ller, R Thiebaut, P Reiss, R Weber, A D'Arminio Monforte, ...
European journal of cardiovascular prevention & rehabilitation 17 (5), 491-501, 2010
3422010
Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya
L Ryom, A Mocroft, O Kirk, SW Worm, DA Kamara, P Reiss, M Ross, ...
The Journal of infectious diseases 207 (9), 1359-1369, 2013
3022013
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study.
LJD m L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA ...
J Infect Dis 207 (9), 1359-69, 2013
3022013
Influence of age on CD4 cell recovery in human immunodeficiency virus–infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study
JP Viard, A Mocroft, A Chiesi, O Kirk, B R°ge, G Panos, N Vetter, ...
The Journal of infectious diseases 183 (8), 1290-1294, 2001
2862001
Serious fatal and nonfatal non-AIDS-defining illnesses in Europe
A Mocroft, P Reiss, J Gasiorowski, B Ledergerber, J Kowalska, A Chiesi, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 55 (2), 262-270, 2010
2662010
Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America
Antiretroviral Therapy Cohort Collaboration
Clinical Infectious Diseases 41 (12), 1772-1782, 2005
2542005
One-pill once-a-day HAART: a simplification strategy that improves adherence and quality of life of HIV-infected subjects
M Airoldi, M Zaccarelli, L Bisi, T Bini, A Antinori, C Mussini, F Bai, ...
Patient preference and adherence 4, 115, 2010
2182010
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study
JP Viard, JC Souberbielle, O Kirk, J Reekie, B Knysz, M Losso, J Gatell, ...
Aids 25 (10), 1305-1315, 2011
2072011
Risk factors for overdose mortality: a case-control study within a cohort of intravenous drug users
M DAVOLI, CA PERUCCI, F FORASTIERE, PAT DOYLE, E RAPITI, ...
International Journal of Epidemiology 22 (2), 273-277, 1993
1711993
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survival
A Mocroft, S Madge, AM Johnson, A Lazzarin, N Clumeck, FD Goebel, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 22 (4), 369-378, 1999
1701999
The system can't perform the operation now. Try again later.
Articles 1–20